PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.15%
Positive revenue growth while ON is negative. John Neff might see a notable competitive edge here.
8.67%
Gross profit growth above 1.5x ON's 0.62%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-18.95%
Negative EBIT growth while ON is at 32.87%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-14.93%
Negative operating income growth while ON is at 32.87%. Joel Greenblatt would press for urgent turnaround measures.
-47.61%
Negative net income growth while ON stands at 1595.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-48.68%
Negative EPS growth while ON is at 1460.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-47.22%
Negative diluted EPS growth while ON is at 1504.96%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.47%
Share reduction more than 1.5x ON's 7.31%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-4.07%
Reduced diluted shares while ON is at 6.75%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
2.45%
Dividend growth of 2.45% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-23.75%
Negative OCF growth while ON is at 14.75%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-222.99%
Negative FCF growth while ON is at 19.44%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
42.96%
10Y CAGR of 42.96% while ON is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-19.24%
Negative 5Y CAGR while ON stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
13.52%
3Y CAGR of 13.52% while ON is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
2418.16%
OCF/share CAGR of 2418.16% while ON is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-16.24%
Negative 5Y OCF/share CAGR while ON is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-19.88%
Negative 3Y OCF/share CAGR while ON stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
7472.52%
10Y net income/share CAGR of 7472.52% while ON is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
105.66%
Net income/share CAGR of 105.66% while ON is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-64.38%
Negative 3Y CAGR while ON is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
287.85%
Equity/share CAGR of 287.85% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
182.94%
Equity/share CAGR of 182.94% while ON is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
76.79%
Equity/share CAGR of 76.79% while ON is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
15.66%
Dividend/share CAGR of 15.66% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-4.26%
Negative 5Y dividend/share CAGR while ON stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-1.77%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
12.58%
Our AR growth while ON is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.11%
Inventory growth well above ON's 5.55%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-6.23%
Negative asset growth while ON invests at 3.38%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.27%
We have a declining book value while ON shows 2.85%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.89%
Debt growth far above ON's 0.20%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
33.25%
R&D growth drastically higher vs. ON's 18.71%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
13.25%
SG&A growth well above ON's 7.11%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.